Filing Flows › Comparisons › ABBV vs BMY
AbbVie vs Bristol Myers Squibb: ABBV and BMY compared
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $13.1B for Bristol Myers Squibb (Q3 2026). AbbVie is growing faster (+10% against +7% a year earlier). AbbVie is more profitable, with an operating margin of 36.0% against 19.4%.
Where the money goes: ABBV and BMY
AbbVie (ABBV) · Q3 2026
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Bristol Myers Squibb (BMY) · Q3 2026
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
| AbbVie (ABBV) | Bristol Myers Squibb (BMY) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $17.4B | $13.1B |
| Revenue growth, Y/Y | +10% | +7% |
| Operating margin | 36.0% | 19.4% |
| Net earnings | $4.2B | $2.2B |
| Net margin | 24.2% | 16.5% |
| Operating cash flow | $7.6B | $4.2B |
| Free cash flow | $7.3B | $3.8B |
| Market value | $516.2B | $127.6B |
| P/E | 50.1× | 13.7× |
| Analysts’ mean target | $310.65 | $65.25 |
Where the revenue comes from
Bristol Myers Squibb
- Net product sales: $12.6B (97%)
- Camzyos: $420M (3%)
Questions
Which is bigger, AbbVie or Bristol Myers Squibb?
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $13.1B for Bristol Myers Squibb (Q3 2026).
Is AbbVie or Bristol Myers Squibb growing faster?
AbbVie is growing faster (+10% against +7% a year earlier).
Which is more profitable, AbbVie or Bristol Myers Squibb?
AbbVie is more profitable, with an operating margin of 36.0% against 19.4%.
More: AbbVie earnings · how AbbVie makes money · Bristol Myers Squibb earnings · how Bristol Myers Squibb makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.